Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Blu-5937
2. Methyl (s)-3-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-7-methylimidazo(1,2-a)pyridin-3-yl)methyl)piperidine-1-carboxylate
1. Blu-5937
2. Tb7d2h7mzz
3. 1621164-74-6
4. (s)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate
5. 4-morpholinecarboxylic Acid, 2-((2-(2,6-difluoro-4-((methylamino)carbonyl)phenyl)-7-methylimidazo(1,2-a)pyridin-3-yl)methyl)-, Methyl Ester, (2s)-
6. Camlipixant [inn]
7. Unii-tb7d2h7mzz
8. Chembl5095035
9. Schembl15923275
10. A935056
11. Methyl (2s)-2-({2-[2,6-difluoro-4- (methylcarbamoyl)phenyl]-7-methylimidazo[1,2- A]pyridin-3-yl}methyl)morpholine-4-carboxylate
12. Methyl (s)-2-((2-(2,6-difluoro-4-(methylcarbamoyl)-phenyl)-7-methylimidazo(1,2-a)pyridin-3-yl)methyl)-morpholine-4-carboxylate
| Molecular Weight | 458.5 g/mol |
|---|---|
| Molecular Formula | C23H24F2N4O4 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 85.2 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 704 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
76
PharmaCompass offers a list of Camlipixant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camlipixant manufacturer or Camlipixant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camlipixant manufacturer or Camlipixant supplier.
PharmaCompass also assists you with knowing the Camlipixant API Price utilized in the formulation of products. Camlipixant API Price is not always fixed or binding as the Camlipixant Price is obtained through a variety of data sources. The Camlipixant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Camlipixant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camlipixant, including repackagers and relabelers. The FDA regulates Camlipixant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camlipixant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Camlipixant supplier is an individual or a company that provides Camlipixant active pharmaceutical ingredient (API) or Camlipixant finished formulations upon request. The Camlipixant suppliers may include Camlipixant API manufacturers, exporters, distributors and traders.
Camlipixant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Camlipixant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Camlipixant GMP manufacturer or Camlipixant GMP API supplier for your needs.
A Camlipixant CoA (Certificate of Analysis) is a formal document that attests to Camlipixant's compliance with Camlipixant specifications and serves as a tool for batch-level quality control.
Camlipixant CoA mostly includes findings from lab analyses of a specific batch. For each Camlipixant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Camlipixant may be tested according to a variety of international standards, such as European Pharmacopoeia (Camlipixant EP), Camlipixant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camlipixant USP).
